Our study about relapse of T-cell acute lymphoblastic leukemia (T-ALL) in adult patients published in Genome Biology

By |2023-11-08T09:54:27+00:00December 17th, 2020|Categories: BG News|

This work performed in collaboration with Hospital del Mar Medical Research Institute and Josep Carreras Leukaemia Research Institute, and supported by Asociación Española Contra el Cáncer [...]

Comments Off on Our study about relapse of T-cell acute lymphoblastic leukemia (T-ALL) in adult patients published in Genome Biology

Our review describing IntoGen titled “A compendium of mutational cancer driver genes” published in Nature Reviews Cancer

By |2023-11-08T09:54:27+00:00September 2nd, 2020|Categories: BG News|Tags: |

In this review, we focus on the history of cancer driver genes identification from the beginning of cancer research through the advent of cancer genomics and [...]

Comments Off on Our review describing IntoGen titled “A compendium of mutational cancer driver genes” published in Nature Reviews Cancer

Our paper on how nucleosomes influence mutation rate leading to a 10bp periodic pattern is out in Cell

By |2023-11-08T09:54:27+00:00November 7th, 2018|Categories: BG News, Uncategorized|Tags: , , , , , |

We are very excited to share that our work describing the somatic and germline 10bp periodicity in the mutation rate within nucleosome-bound DNA was published in the [...]

Comments Off on Our paper on how nucleosomes influence mutation rate leading to a 10bp periodic pattern is out in Cell

Our paper on reduced mutation rate in exons due to differential mismatch repair published in Nature Genetics

By |2023-11-08T09:54:27+00:00November 7th, 2017|Categories: BG News, Uncategorized|

We are happy to announce that our paper on reduced mutation burden in exons caused by differential mismatch repair has been published yesterday, 6th November in Nature [...]

Comments Off on Our paper on reduced mutation rate in exons due to differential mismatch repair published in Nature Genetics

A Cancer Genome Interpreter to identify driver and actionable alterations in tumors

By |2023-11-08T09:54:28+00:00October 5th, 2016|Categories: BG News|Tags: , , |

The use of genomic information is becoming a key piece of the oncology toolkit to make informed decisions aimed to improve the management of the disease and increase the cost-effectiveness of available therapies.

Comments Off on A Cancer Genome Interpreter to identify driver and actionable alterations in tumors
Go to Top